Zentalis Pharmaceuticals Ownership | Who Owns Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals Ownership Summary
Zentalis Pharmaceuticals is owned by 99.79% institutional investors, 3.47% insiders. Matrix capital management company, lp is the largest institutional shareholder, holding 19.69% of ZNTL shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 6.96% of its assets in Zentalis Pharmaceuticals shares.
ZNTL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Zentalis Pharmaceuticals | 99.79% | 3.47% | -3.26% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Matrix capital management company, lp | 13.96M | 19.69% | $57.10M |
| Fmr | 8.68M | 12.24% | $35.49M |
| Eventide asset management | 8.55M | 12.06% | $34.96M |
| Vanguard group | 5.65M | 7.98% | $23.13M |
| Blackrock | 4.82M | 6.80% | $19.71M |
| Decheng capital | 3.07M | 4.33% | $12.56M |
| State street | 3.05M | 4.31% | $12.48M |
| Morgan stanley | 1.95M | 2.75% | $7.98M |
| Woodline partners lp | 1.52M | 2.14% | $6.20M |
| Bioimpact capital | 1.45M | 2.05% | $5.93M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mayo clinic | 187.14K | 25.27% | $765.41K |
| Decheng capital | 3.07M | 3.85% | $12.56M |
| Bioimpact capital | 1.45M | 0.92% | $5.93M |
| Tybourne capital management (hk) | 961.49K | 0.80% | $3.93M |
| Eventide asset management | 8.55M | 0.60% | $34.96M |
| 5am venture management | 490.00K | 0.45% | $2.00M |
| Matrix capital management company, lp | 13.96M | 0.43% | $57.10M |
| Values first advisors | 74.92K | 0.18% | $306.44K |
| Boxer capital | 450.00K | 0.10% | $1.84M |
| Regency capital management inc.\de | 29.50K | 0.08% | $120.66K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | 5.65M | 0.00% | 1.26M |
| Decheng capital | 3.07M | 3.85% | 970.86K |
| Morgan stanley | 1.95M | 0.00% | 913.31K |
| Two sigma investments, lp | 1.05M | 0.01% | 807.40K |
| Two sigma advisers, lp | 796.90K | 0.01% | 695.90K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Eventide asset management | 8.55M | 0.60% | -3.03M |
| Price t rowe associates inc /md/ | 923.90K | 0.00% | -2.57M |
| Fmr | 8.68M | 0.00% | -1.97M |
| Federated hermes | 482.48K | 0.00% | -1.52M |
| T. rowe price investment management | - | - | -1.33M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Y-intercept (hong kong) | 103.92K | 0.02% | 103.92K | $425.02K |
| Virtu financial | 93.19K | 0.03% | 93.19K | $381.00K |
| Norges bank | 71.53K | - | 71.53K | $292.55K |
| Sherbrooke park advisers | 41.34K | 0.03% | 41.34K | $169.08K |
| Mirae asset global etfs | 35.59K | 0.00% | 35.59K | $146.28K |
Sold Out
| Holder | Change |
|---|---|
| Gamma investing | -2.00 |
| Nelson, van denburg & campbell wealth management group | -11.00 |
| Riggs asset managment | -23.00 |
| Quadrant capital group | -24.00 |
| Cwm | -39.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 137 | -4.86% | 70,963,212 | -7.43% | 99 | 0.85% | 71 | -13.41% | 38 | -5.00% |
| Jun 30, 2024 | 144 | 2.13% | 76,655,527 | -9.95% | 108 | 0.75% | 82 | 5.13% | 40 | 11.11% |
| Mar 31, 2024 | 141 | 14.63% | 85,130,112 | 5.09% | 120 | 0.92% | 78 | 20.00% | 36 | 12.50% |
| Dec 31, 2023 | 123 | -12.14% | 81,004,402 | 1.25% | 114 | 0.89% | 65 | -2.99% | 32 | -17.95% |
| Sep 30, 2023 | 140 | 2.94% | 80,005,920 | -2.95% | 113 | 0.62% | 67 | -27.96% | 39 | 50.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 4.95M | 6.96% | -1.63M |
| Eventide Gilead N | 3.58M | 5.04% | -1.39M |
| Vanguard Total Stock Mkt Idx Inv | 1.89M | 2.66% | - |
| iShares Russell 2000 ETF | 1.43M | 2.01% | -3.22K |
| Fidelity Growth Compy Commingled Pl O | 1.16M | 1.63% | - |
| PRIMECAP Odyssey Aggressive Growth | 1.10M | 1.55% | 217.93K |
| Vanguard Institutional Extnd Mkt Idx Tr | 896.55K | 1.26% | - |
| FIAM Small Cap Core CIT Cl B | 886.80K | 1.25% | 11.50K |
| Fidelity Growth Compy Commingled Pl S | 881.46K | 1.24% | -280.77K |
| FIAM Small Cap Core Composite | 866.20K | 1.22% | 289.81K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 04, 2024 | Vultaggio Vincent | Principal Accounting Officer | Sell | $5.10K |
| May 31, 2024 | Gallagher Cam | President, Interim CFO | Sell | $114.97K |
| May 09, 2024 | HAUSMAN DIANA | Chief Medical Officer | Sell | $42.35K |
| Feb 12, 2024 | Epperly Melissa B, | Chief Financial Officer | Sell | $29.44K |
| Feb 12, 2024 | Gallagher Cam | President | Sell | $13.42K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 1 |
| 2024 Q2 | - | 2 |
| 2024 Q1 | - | 6 |
| 2023 Q4 | 2 | 6 |
| 2023 Q3 | - | 1 |
ZNTL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools